OtherBrief Communication
Open Access

Prevalence and characteristics of abnormal Papanicolaou smear in Central Saudi Arabia

Hanan M. Al-Kadri, Mehak Kamal, Samira S. Bamuhair, Aamir A. Omair and Hana S. Bamefleh
Saudi Medical Journal January 2015, 36 (1) 117-122; DOI: https://doi.org/10.15537/smj.2015.1.9141

References

  1. ↵
    1. Altaf FJ
    (2006) Cervical cancer screening with pattern of pap smear. Review of multicenter studies. Saudi Med J 27:1498–1502.
    OpenUrlPubMed
    1. Al-Zahrani AS,
    2. Ravichandran K
    (2007) Cervical cancer screening with pattern of Pap smear. Review of multicenter studies. Saudi Med J 28:1305.
    OpenUrlPubMed
  3. ↵
    1. Elhakeem HA,
    2. Al-Ghamdi AS,
    3. Al-Maghrabi JA
    (2005) Cytopathological pattern of cervical Pap smear according to the Bethesda system in Southwestern Saudi Arabia. Saudi Med J 26:588–592.
    OpenUrlPubMed
  4. ↵
    1. Jamal A,
    2. Al-Maghrabi JA
    (2003) Profile of Pap smear cytology in the Western region of Saudi Arabia. Saudi Med J 24:1225–1229.
    OpenUrlPubMed
  5. ↵
    1. de Sanjose S,
    2. Quint WG,
    3. Alemany L,
    4. Geraets DT,
    5. Klaustermeier JE,
    6. Lloveras B,
    7. et al.
    (2010) Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study. Lancet Oncol 11:1048–1056.
    OpenUrlCrossRefPubMedWeb of Science
  6. ↵
    1. Paavonen J,
    2. Naud P,
    3. Salmeron J,
    4. Wheeler CM,
    5. Chow SN,
    6. Apter D,
    7. et al.
    (2009) Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women. Lancet 374:301–314.
    OpenUrlCrossRefPubMedWeb of Science
  7. ↵
    Ministry of Economy and Planning. Development indicators. Available from: http://www.cdsi.gov.sa/echonomy/layouts. Accessed 2014 Feb 12.
  8. ↵
    Central Department of Statistical and Information. Estimates of the population by sex and nationality. Available from: http://www.cdsi.gov.sa/socandpub/resd. Accessed 2014 Feb 12.
  9. ↵
    1. Habbema D,
    2. De Kok IM,
    3. Brown ML
    (2012) Cervical cancer screening in the United States and the Netherlands: a tale of two countries. Milbank Q 90:5–37.
    OpenUrlCrossRefPubMedWeb of Science
  10. ↵
    1. Rebolj M,
    2. van Ballegooijen M,
    3. van Kemenade F,
    4. Looman C,
    5. Boer R,
    6. Habbema JD
    (2008) No increased risk for cervical cancer after a broader definition of a negative Pap smear. Int J Cancer 123:2632–2635.
    OpenUrlCrossRefPubMed
  11. ↵
    1. Kobilková J,
    2. Masata J,
    3. Janousek M,
    4. Strunová M
    (2003) [What the Bethesda II/2001 System can give to gynecologists and what they require]. Ceska Gynekol 68:346–352, Czech.
    OpenUrlPubMed
  12. ↵
    1. Solomon D,
    2. Davey D,
    3. Kurman R,
    4. Moriarty A,
    5. O’Connor D,
    6. Prey M,
    7. et al.
    (2002) The 2001 Bethesda System: terminology for reporting results of cervical cytology. JAMA 287:2114–2119.
    OpenUrlCrossRefPubMedWeb of Science
  13. ↵
    1. Apgar BS,
    2. Zoschnick L,
    3. Wright TC Jr.
    (2003) The 2001 Bethesda System terminology. Am Fam Physician 68:1992–1998.
    OpenUrlPubMedWeb of Science
  14. ↵
    1. Berek JS
    (2003) Simplification of the new Bethesda 2001 classification system. Am J Obstet Gynecol 188(3 Suppl):S2–S5.
    OpenUrlPubMed
  15. ↵
    1. Altaf FJ,
    2. Mufti ST
    (2011) Pattern of cervical smear abnormalities using the revised Bethesda system in a tertiary care hospital in Western Saudi Arabia. J Cytol 28:173–177.
    OpenUrlPubMed
  16. ↵
    1. Balaha MH,
    2. Al Moghannum MS,
    3. Al Ghowinem N,
    4. Al Omran S
    (2011) Cytological pattern of cervical Papanicolaou smear in eastern region of Saudi Arabia. J Cytol 28:173–177.
    OpenUrlPubMed
  17. ↵
    1. Kapila K,
    2. George SS,
    3. Al-Shaheen A,
    4. Al-Ottibi MS,
    5. Pathan SK,
    6. Sheikh ZA,
    7. et al.
    (2006) Changing spectrum of squamous cell abnormalities observed on Papanicolaou smears in Mubarak Al-Kabeer Hospital, Kuwait, over a 13-year period. Med Princ Pract 15:253–259.
    OpenUrlPubMed
  18. ↵
    1. Ghazal-Aswad S,
    2. Gargash H,
    3. Badrinath P,
    4. Al-Sharhan MA,
    5. Sidky I,
    6. Osman N,
    7. et al.
    (2006) Cervical smear abnormalities in the United Arab Emirates: a pilot study in the Arabian Gulf. Acta Cytol 50:41–47.
    OpenUrlPubMed
  19. ↵
    1. Banik U,
    2. Bhattacharjee P,
    3. Ahamad SU,
    4. Rahman Z
    (2011) Pattern of epithelial cell abnormality in Pap smear: A clinicopathological and demographic correlation. Cytojournal 8:8.
    OpenUrlPubMed
  20. ↵
    1. Abdullah LS
    (2007) Pattern of abnormal Pap smears in developing countries: a report from a large referral hospital in Saudi Arabia using the revised 2001 Bethesda System. Ann Saudi Med 27:268–272.
    OpenUrlPubMed
  21. ↵
    1. Kiatiyosnusorn R,
    2. Suprasert P,
    3. Srisomboon J,
    4. Siriaree S,
    5. Khunamornpong S,
    6. Kietpeerakool C
    (2010) High-grade histologic lesions in women with low-grade squamous intraepithelial lesion cytology from a region of Thailand with a high incidence of cervical cancer. Int J Gynaecol Obstet 110:133–136.
    OpenUrlPubMed
  22. ↵
    1. Kim JW,
    2. Song SH,
    3. Jin CH,
    4. Lee JK,
    5. Lee NW,
    6. Lee KW
    (2012) Factors affecting the clearance of high-risk human papillomavirus infection and the progression of cervical intraepithelial neoplasia. J Int Med Res 40:486–496.
    OpenUrlPubMed
  23. ↵
    1. Maucort-Boulch D,
    2. Plummer M,
    3. Castle PE,
    4. Demuth F,
    5. Safaeian M,
    6. Wheeler CM,
    7. et al.
    (2010) Predictors of human papillomavirus persistence among women with equivocal or mildly abnormal cytology. Int J Cancer 126:684–691.
    OpenUrlCrossRefPubMedWeb of Science
  24. ↵
    1. Gavric-Lovrec V,
    2. Takac I
    (2010) Use of various contraceptives and human papillomavirus 16 and 18 infections in women with cervical intraepithelial neoplasia. Int J STD AIDS 21:424–427.
    OpenUrlCrossRefPubMed
  25. ↵
    1. Yasmin S,
    2. Mukherjee A
    (2012) A cyto-epidemiological study on married women in reproductive age group (15-49 years) regarding reproductive tract infection in a rural community of West Bengal. Indian J Public Health 56:204–209.
    OpenUrl
  26. ↵
    1. Castellsague X,
    2. Diaz M,
    3. Vaccarella S,
    4. de Sanjose S,
    5. Munoz N,
    6. Herrero R,
    7. et al.
    (2011) Intrauterine device use, cervical infection with human papillomavirus, and risk of cervical cancer: a pooled analysis of 26 epidemiological studies. Lancet Oncol 12:1023–1031.
    OpenUrlCrossRefPubMedWeb of Science
  27. ↵
    1. Madani TA
    (2006) Sexually transmitted infections in Saudi Arabia. BMC Infect Dis 6:3.
    OpenUrlCrossRefPubMed
  28. ↵
    1. Al-Kadri HM,
    2. Hajeer AH,
    3. Al-Hawashim NS,
    4. Salem HH
    (2006) The significance of documenting clinical appearance of the uterine cervix in the cervical cytology form. Saudi Med J 27:447–451.
    OpenUrl
  29. ↵
    1. Sharpless KE,
    2. O’Sullivan DM,
    3. Schnatz PF
    (2009) The utility of human papillomavirus testing in the management of atypical glandular cells on cytology. J Low Genit Tract Dis 13:72–78.
    OpenUrlPubMed
  30. ↵
    1. Crothers JW,
    2. Mount SL,
    3. Harmon M,
    4. Wegner E
    (2015) The utility of human papillomavirus testing in young women with atypical glandular cells on pap test. J Low Genit Tract Dis 9:22–26.
    OpenUrl
Back to top

In this issue

Print
Download PDF
Email Article
Citation Tools
Bookmark this article

Jump to section